Visual hallucinatory syndromes: past, present, and future by ffytche, Dominic H.
isual hallucinations came of age in 1936 with the
publication of two clinical reviews.The first,a modest 2-
page essay, appeared in the relative backwater of a
parochial Swiss medical journal,authored by George de
Morsier,then a recently appointed lecturer in neurology.
1
The second appeared in the Annales Médico-
Psychologiques,the high-profile voice of French-speak-
ing psychiatry, coauthored by the neurologist Jean
L’Hermitte,an established expert in the field following
his earlier description of peduncular hallucinations,and
the psychiatrist Julian de Ajuriaguerra,then aged 25 and
at the beginning of his career.
2 Both reviews shared three
important breaks with tradition.First,visual hallucina-
tions were deemed worthy of study in their own right,
distinct from hallucinations in other modalities and from
other forms of psychopathology.Second,they were to be
considered a unitary symptom.An earlier generation of
psychiatrists had hoped that different types of visual hal-
lucination might carry different diagnostic implications;
however, from here on, the important clinical detail
became whether a given patient experienced visual hal-
lucinations of any kind, not whether they had halluci-
nated a simple lattice pattern as opposed to a procession
of animals or an elaborately costumed figure,for exam-
ple.The third break with tradition was to distance visual
hallucinations from visual illusions,giving them a higher
clinical status.Yet,although sharing much in common,the
two papers differed in their conception of the brain and
its disorders.L’Hermitte and de Ajuriaguerra looked for-
ward to emerging holistic models of psychopathology,
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In 1936, two clinical reviews, one by de Morsier, the other
by L’Hermitte and de Ajuriaguerra, formulated an
approach to visual hallucinations that continues to this
day. Breaking with previous traditions, the papers cham-
pioned visual hallucinations as worthy of study in their
own right, de-emphasizing the clinical significance of their
visual contents and distancing them from visual illusions.
De Morsier described a set of visual hallucinatory syn-
dromes based on the wider neurological and psychiatric
context, many of which remain relevant today; however,
one—the Charles Bonnet Syndrome—sparked 70 years of
controversy over the role of the eye. Here, the history of
visual hallucinatory syndromes and the eye dispute is
reviewed, together with advances in perceptual neuro-
science that question core assumptions of our current
approach. From a neurobiological perspective, three syn-
dromes emerge that relate to specific dysfunctions of
afferent, cholinergic and serotonergic visual circuitry and
promise future therapeutic advances.      
© 2007, LLS SAS Dialogues Clin Neurosci. 2007;9:173-189.viewing visual hallucinations as part of a general halluci-
natory state.Although classifying the clinical conditions
associated with visual hallucinations by the location of
the underlying visual system lesion,their scheme was not
intended to imply a range of distinct syndromes.In con-
trast,de Morsier’s approach looked back to the classical
era of associationism (see ref 3),viewing visual halluci-
nations as a localizing neurological symptom that,when
considered in its wider clinical context,formed distinct
syndromic entities.This syndromic approach captured the
clinical imagination and remains an important influence
today,in part the result of later disagreement between de
Morsier and de Ajuriaguerra over the role of the eye in
visual hallucinations.In order to understand the origin of
de Morsier’s syndromes,we must first turn to the Parisian
Central Police station.
de Clérambault and the origins 
of hallucinatory syndromes
The Special Infirmary of the Parisian Central Police sta-
tion (the Dépôt) held a particular mix of clinical cases.
Differing from other psychiatric centers in Paris,it was
responsible for the assessment of police detainees with
behavioral disturbances and, in consequence, held a
heavy caseload of delirium,dementia,and chronic hallu-
cinatory psychosis.Gaétan de Clérambault (1872-1934)
was appointed director in 1921,but had been associated
with the Special Infirmary since 1905,
4 developing a gen-
eral theory of psychopathology based on the case mix –
the theory of mental automatisms. Influenced by
Wernicke’s associationist school (see ref 3), de
Clérambault viewed psychosis as the sum of core neuro-
logical symptoms,each related to dysfunction in a spe-
cific brain system (see ref 5 for further details).Aberrant
neural activity was propagated from one brain region to
another along anatomical pathways, the linked neuro-
logical symptoms forming stereotyped neuropsychiatric
syndromes. Georges de Morsier studied under de
Clérambault and carried an interest in psychiatric phe-
nomena,particularly hallucinations,to Geneva.In 1930
he published a critique of Bleuler’s and Freud’s psycho-
logical theories of hallucinations,in which he argued that
future advances could only be made through the neuro-
physiological study of hallucinations,although the tech-
niques required were not yet available.
6 His interim solu-
tion was to use lesion evidence as an indirect guide to
dysfunctional neurophysiology and,in the aftermath of
de Clérambault’s suicide of 1934, he published two
homages to his former mentor using this method.The
later work of 1938,Les Hallucinations:étude Oto-neuro-
ophtalmologique,
7 covered hallucinations in all sensory
modalities and opened with a dedication to de
Clérambault’s memory.The earlier work of 1936 focused
on visual hallucinations and honored de Clérambault by
paraphrasing his mental automatism terminology in the
title, Visual Automatisms: Retrochiasmatic Visual
Hallucinations.
1The topic seemed appropriate,as visual
hallucinations had been relatively unexplored in de
Clérambault’s later work.However,there was another
reason for de Morsier to focus on visual hallucinations
alone—he had just developed a novel anatomical theory.
The early 20th century visual system
Although the division of the visual system into visu-
osensory and visuopsychic components was first formu-
lated in the 19th century,it was the Australian neurolo-
gist,psychiatrist,and pathologist,Alfred Walter Campbell
(1868-1937) who in 1905 provided anatomical evidence
in support of the functional dichotomy.
8 Campbell had
described two cyto- and myeloarchitectonically distinct
regions in the occipital lobe of the human brain.The stri-
ate cortex received connections from the lateral genicu-
late nucleus (the geniculo-striate pathway) and sent
fibers to the surrounding cortex,which in turn sent pro-
jections to the pulvinar, temporal, and frontal lobes.
Campbell argued that the striate cortex received crude
sensory impressions,implying a visuosensory function for
the region.In contrast,the surrounding cortex received
more complex inputs,implying a visuopsychic function,
further elaborated through temporal and frontal projec-
tions.A link between the geniculo-striate pathway and
visual hallucinations had first been recognized in 1886 by
Seguin,
9 who described the occurrence of visual halluci-
nations within a visual field defect.De Morsier had pre-
sented a case at an international congress in London in
1935 with hemifield visual hallucinations without a visual
field defect,and had concluded that visual hallucinations
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Selected abbreviations and acronyms
CBS Charles Bonnet syndrome
PD Parkinson’s disease
AD Alzheimer’s disease
HPPD hallucinogen persisting perception disorder
PPVP persistent positive visual phenomenacould also be associated with lesions of the paravisual
sphere,a term he attributed to Hoff and Pötzl describing
connections between the pulvinar and visual cortices (see
ref 10 for a recent anatomical description).
Visual hallucinatory syndromes past: 
de Morsier’s syndromes
De Morsier’s 1936 and 1938 papers viewed visual hallu-
cinations as a stereotyped automatism of the broadly
defined visual system including the paravisual sphere and
temporal lobes.Damage to the system at different loca-
tions would associate visual hallucinations with varying
combinations of motor,vestibular,and auditory symp-
toms and, with a lifelong interest in the history of the
field,
11 de Morsier attached names to the resulting syn-
dromic entities,outlined in Table I.The main part of his
1936 work was a syndrome he named after Hermann
Zingerle (1870-1935),an Austrian neurologist from Graz
with an interest in motor automatisms.This consisted of
visual hallucinations in the context of oculogyric crisis,
persistent movement disorder, and central vestibular
symptoms attributed to lesions of the parietal lobe.The
modern equivalent would perhaps be the positive visual
phenomena (typically intensification of visual patterns
and letters) associated with neuroleptic-induced oculo-
gyric crises.
12,13 De Morsier also honoured de Clérambault
with a syndrome—not erotomania but the chronic hal-
lucinatory psychosis which had helped derive the theory
of mental automatisms.L’Hermitte was honoured with
the peduncular syndrome,although de Morsier argued
that the important lesion was in the pulvinar, not the
cerebral peduncles.Other visual hallucinatory syndromes
he described were not named.One concerned the visual
hallucinations found in delirium tremens that had been
studied by his friend and colleague in Geneva,Ferdinand
Morel.These hallucinations had the unusual property of
being precipitated when one eye was covered,typically
the eye with better acuity,and were located in the central
10 to 15 degrees of the visual field.Neurodegenerative,
vascular,neoplastic,toxic,traumatic,inflammatory,and
epileptic etiologies were also included.Although incom-
plete,much of de Morsier’s classification remains rele-
vant today,some of his notable omissions conditions that
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Table I. de Morsier’s classification of visual hallucinatory syndromes.
Syndrome Symptom pattern Hypothesized cause
Charles Bonnet syndrome  Visual hallucinations in old age without dementia Selective degeneration of pulvino-cortical pathways
Neurodegenerative  Dementia and visual hallucinations Visual system involvement in Alzheimer’s or 
Pick’s disease
Zingerle syndrome Forced movements, vestibular symptoms, and  Parietal lesion involving vestibular, motor,
hemianopic visual hallucinations and pulvino-cortical pathways
L’Hermitte syndrome  Lateralized pain, paresthesiae, sensory loss Pulvinar lesion
(diencephalic/peduncular  and visual hallucinations/oculomotor nerve palsies
lesions ) and visual hallucinations
de Clérambault syndrome  Auditory and visual hallucinations in chronic  Combined temporal, parietal, and occipital 
(mental automatisms)  psychosis dysfunction
Vascular lesions of the  Visual hallucinations in association with a visual Infarct of visual cortex/pathways
occipital lobe  field defect
Cerebral tumors/ Visual hallucinations and localizing signs of Visual system involvement in occipital, temporal,
intracranial hypertension space-occupying lesion or parietal lobe lesions/3rd, 4th ventricle tumours
Inflammation Visual hallucinations in context of delirium Excitation of extended visual system by encephalitis /
fever
Intoxication Visual hallucinations in context of delirium Excitation of extended visual system by atropine, 
digitalis, barbiturates, insulin, mescaline, hashish
Epilepsy Visual hallucinations in context of epilepsy Seizure involving extended visual system
Cerebral trauma  Acute and chronic visual hallucinations following  Involvement of extended visual system
traumatic injury
Monocular hallucinations Central field scotoma with hallucinations Combined retrobulbar and cerebral factors, 
eg, delirium tremenshad yet to be described. Current classifications would
include dementia with Lewy bodies (DLB) and nar-
colepsy (visual hallucinations forming part of the diag-
nostic criteria in these disorders), Parkinson’s disease
(PD),migraine,bereavement,lysergic acid diethylamide
(LSD),3,4-methylenedioxymethamphetamine (MDMA-
ecstasy), visual sensory deprivation, and stroboscopic
stimulation (Table II;see refs 14,15 for recent reviews).
However, de Morsier’s classification is perhaps most
remembered for one syndrome, mentioned in passing,
that sparked a 70-year controversy.
The Charles Bonnet syndrome 
De Morsier included a brief mention of a syndrome
inferred from reports in the literature.Charles Bonnet’s
description of the visual hallucinations experienced by
his 89-year-old grandfather Charles Lullin (see ref 14 for
detailed account) had been largely overlooked in the
early 20th century visual hallucination literature.
However, the account was well known to de Morsier
through accidents of birth and geography. His mother
was related to Theodore Flournoy and Edouard
Calparède,cousins themselves and founding editors of
the Archives of Psychology.Flournoy had inaugurated
the first issue with a commentary and transcript of
Lullin’s original observations that survived in the collec-
tions of a surgeon,
16 and in 1909 an autobiographical
report of the 92-year-old philosopher Ernest Naville’s
visual hallucinations were published in the same jour-
nal.
17 Bonnet,Lullin,Naville,Flournoy,and the Archives
of Psychology were all linked to Geneva— then,and for
the remainder of his life,de Morsier’s home.Basing his
syndrome on these published accounts, he argued that
visual hallucinations could occur in the absence of cog-
nitive impairment in the elderly,a syndrome he referred
to as the Charles Bonnet syndrome (CBS). For de
Morsier,CBS implied a localized neurodegeneration and
contrasted the association of visual hallucinations and
dementia in Alzheimer's disease (AD) and Pick’s dis-
ease.Although he did not specify the site of the theoret-
ical neurodegenerative lesion,he later revealed his sus-
picion that it involved the paravisual sphere,
18 the
pulvino-cortical connections he had linked to visual hal-
lucinations in 1935.
The ocular theory 
Although de Morsier was unable to confirm his neu-
rodegenerative hypothesis,he was certain of one thing:
CBS had nothing to do with eye disease.For him the fact
that Charles Lullin had impaired vision was no more
than a coincidence of the fact that eye problems were
common in the elderly. His position was to influence
developments in the field for the next 70 years,and had
its roots in a debate that had taken place the previous
decade in the ophthalmological literature.A French oph-
thalmologist, Victor Morax (1866-1935) had provided
what seemed to be compelling clinical evidence of a link
between eye disease and visual hallucinations in 1922.
19
He had presented a case with an exact temporal corre-
spondence of visual loss and the onset of figure and land-
scape hallucinations.Morax’s derived a theory of their
cause based on positive scotoma,dark areas of the visual
field related to retinal lesions. He argued that positive
scotoma occurred when aberrant retinal impulses were
conducted to the brain,and were absent when such con-
duction could not take place,for example through reti-
nal fiber loss.Visual hallucinations in eye disease were
simply a more elaborate form of positive scotoma in
which the aberrant retinal signals were conducted
beyond the visual cortex to its associative centers.Other
ophthalmologists joined Morax with further reports of
temporal associations (eg,Truc
20) and two psychiatrists,
Brunerie and Cloche, presented a case in which visual
hallucinations resolved after a cataract operation.
21
Arthur Ormond,an ophthalmologist at Guy’s hospital in
London,published his own cases in 1925
22 and,influenced
by Galton’s work on visual imagery,concluded that visual
hallucinations were related to a hypersensitivity of spe-
cialized visual cortical areas,triggered in some cases by
eye disease.
Yet not all ophthalmologists agreed with the ocular the-
Clinical research
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Table II. Visual hallucinatory syndromes not included by de Morsier. LSD,
lysergic acid diethylamide; MDMA, 3,4-methylenedioxymetham-
phetamine; PTSD, post-traumatic stress disorder
Eye disease (specifically excluded) 
Parkinson’s disease
Lewy body dementia 
Narcolepsy
Migraine
LSD/MDMA (ecstasy)
PTSD
Sensory deprivation
Stroboscopic stimulationory.In France,Terson summarized in a single phrase the
seemingly incontrovertible evidence against the eye as a
primary cause of visual hallucinations:“[...]consider the
vast number of cases of eye disease without hallucina-
tions and hallucinations without eye disease.”
23
In his view,additional toxic or inflammatory brain fac-
tors were invariable in such patients.Eye disease itself
could not be an important factor as visual hallucinations
could occur without it, in its presence or after it had
resolved.L’Hermitte and de Ajuriaguerra’s 1936 paper
added further weight to Terson’s counterargument with
post-mortem evidence of a patient with visual hallucina-
tions in which thalamic lesions were found in addition to
eye disease.
2They also argued that aberrant retinal sig-
nals could at best only engender simple hallucinatory
forms and should cease with eye closure,a maneuver that
only seemed to influence hallucinations in a few patients.
They did not dismiss the possible role of the eye but
believed it,at best,a secondary factor.De Morsier incor-
porated this view into his 1936 and 1938 papers, citing
L’Hermitte as having disproved the ocular theory.For de
Morsier,eye disease was not the cause of CBS,or indeed
visual hallucinations under any circumstances,and was
specifically excluded from his classification.However,it
is clear that in 1938 at least,de Morsier’s opposition to
the eye was specific to the aberrant retinal impulse the-
ory.In response to the commentary on his 1938 paper,he
agreed with Velter that a reduction in acuity through eye
disease might provoke visual hallucinations,
24 a view that
differs little from modern deafferentation theory (see
below).Yet circumstances were later to push de Morsier
even further from this concession to the eye.
Charles Bonnet Syndrome defined by eye disease
De Morsier’s Charles Bonnet eponym was immediately
popular,other clinicians using the term by the time his
response to the commentary on his 1938 paper was pub-
lished.
24 Yet, although CBS survived the second world
war,his insistence that it was unrelated to eye disease did
not. In 1956, Hécaen and Garcia Badaracco acknowl-
edged de Morsier for introducing CBS but did not agree
with his antiophthalmological stance,shifting the defin-
ition to the very ground de Morsier had tried to dis-
miss—visual hallucinations in eye disease.
25 For Hécaen
and Garcia Badaracco, as for L’Hermitte and de
Ajuriaguerra 20 years before,it was the combination of
eye and cerebral pathology that resulted in visual hallu-
cinations, a dual pathology encapsulated in Bonnet’s
description of the elderly,visually impaired Lullin.The
redefinition constituted a blow to de Morsier’s intended
syndrome,but it was the return of de Ajuriaguerra that
finally sealed its fate.
De Ajuriaguerra was appointed Director of Psychiatry at
the University of Geneva in 1959,overlapping the last 5
years of de Morsier’s tenure as Director of Neurology.In
the year of de Morsier’s retirement,he organized an inter-
national conference on the psychopathology of deaf-
ferentation,referring to CBS in his own presentation with
Garrone as “visual hallucinations in eye disease.” de
Morsier was mentioned in passing amongst authors who
had written on the topic,but de Ajuriaguerra cited his own
work with L’Hermitte and that of Hécaen and Garcia
Badaracco as the two major previous reviews.
26The fol-
lowing year,with coauthors Burgermeister and Tissot,he
presented afresh the clinical details of the six cases he had
first described with L’Hermitte,relabeling them as CBS.
27
His position had shifted slightly in the intervening 29 years,
the eye and brain now carrying equal weight as causal fac-
tors, as opposed to the eye as secondary to the brain.
Visual hallucinations occurred transiently in patients with
pre-existing eye disease when infection,intoxication,or
physical debilitation compromised brain function;equally,
visual hallucinations occurred in patients with pre-existing
brain disease as their vision deteriorated.De Ajuriaguerra
viewed the cause of visual hallucinations as a continuum
of brain and eye contributions rather than a series of dis-
crete syndromic entities.In delirium tremens the brain was
primarily responsible with little contribution from the eye;
in CBS the eye and brain carried equal weight as factors;
in post-surgical eye patching,the eye was more important
than the brain. In retaliation, de Morsier published his
major work on CBS 3 years after retirement.
28This was a
scholarly review of the classical literature,including a fac-
simile of the two key pages in Bonnet’s 18th-century work.
However,de Morsier was more concerned with defending
his original definition than appraising the emerging eye-
brain model,and the damage had been done.For the next
two decades,CBS led a parallel existence in the literature,
joined in the 1980s by a third definition.
Classical phenomenological syndromes
Perhaps obscured by later controversy surrounding the
role of the eye,little attention was paid to key shifts in
the approach to visual hallucinations instituted in 1936
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earlier generation of clinicians,differences in the clinical
significance of visual illusions and visual hallucinations
had been less absolute.Furthermore,visual hallucinations
had not been a single pathological symptom—there had
been several distinct types of visual hallucination based
on phenomenological characteristics such as their con-
tent,form,and emotional associations.The hope of early
20th-century clinicians was that a specific hallucination
phenomenology might indicate a specific clinical condi-
tion. For example, de Clérambault compared the neu-
ropsychiatric manifestations of chloral hydrate,alcohol,
and cocaine,and found in the visual domain,specific to
chloral hydrate,20- to 30-cm hallucinations of writing,
miniature landscapes, or figures projected onto a sur-
rounding wall.
29 Some of these early phenomenological
syndromes are described below,together with their mod-
ern vestiges.
The syndrome of Lilliputian hallucinations
Shortly after his election to the Société Médico-
Psychologique by de Clérambault in 1909,
30 Raoul Leroy
presented a paper concerning multiple small,colored fig-
ures associated with a pleasant affect.
31 de Clérambault
pointed out that his chloral hydrate patients had been
indifferent rather than amused by the phenomena,and
that giant hallucinations were also found.Apart from the
published proceedings of a meeting the following year,
32
Leroy deferred to de Clérambault and wrote no further
on the topic for a decade. In the 1920s, he published a
series of accounts in both the French and English litera-
ture, building on his original observations.
33-36 His syn-
drome of Lilliputian hallucinations consisted of:
[…] small people,men or women of minute or slightly variable
height;either above or accompanied by small animals or small
objects all relatively proportionate in size,with the result that
the individual must see a world such as created by Swift in
Gulliver.These hallucinations are mobile,coloured,generally
multiple. It is a veritable Lilliputian vision. Sometimes it is a
theatre of small marionettes,scenes in miniature which appear
to the eyes of the surprised patient.All this little world,clothed
generally in bright colours,walks,runs,plays and works in relief
and perspective;these microscopic visions give an impression
of real life.
35
In a concession to de Clérambault,Leroy now noted the
hallucinations were only pleasurable in typical cases,con-
trasting with delirious hallucinations which were unpleas-
ant, one state often following the other in the same
patient.
36 He also added that Lilliputian hallucinations
were silent,although were occasionally associated with
Lilliputian voices.
35The syndrome was initially described
as specific to alcohol or drug-related toxicity, but later
examples were given of infective and neurodegenerative
causes.Although the syndrome is not referred to today,
elements were incorporated into Damas-Mora et al’s
redefinition of CBS (see below).
Zoopsia
When Leroy contrasted his syndrome with the unpleas-
ant visual hallucinations of delirium, he was indirectly
referring to the long-recognized association of fear with
visual hallucinations in the context of delirum tremens.
These hallucinations could be swarms of small animals
(eg,ants,beetles or mice,etc) or isolated groups of larger
animals (eg,tigers,elephants,birds,and dogs) and,in the
early 20th century, were referred to as zoopsia. Morel
produced an account of how the species of animal hallu-
cinated depended on the distance of the surface on which
it was projected – mice if 1 metre,pigeons if 2 metres,cats
and rabbits if 3 metres,and so forth.
37 de Morsier argued
against the use of the term as it implied an alcohol-
related etiology,whereas,in fact,animal hallucinations
were found in a range of conditions.
24 Today, 51% of
patients with visual hallucinations in delirium tremens
describe animal hallucinations; however, they are sur-
passed by figure (82%) and object (61%) forms.
38 Similar
relative frequencies are found in PD.
39
Simple versus complex
As outlined above, the early 20th-century view of the
visual system was of a broad division into crude visu-
osensory and elaborated visuopsychic functions.This 
fitted well with the simple/complex hallucination
dichotomy found in clinical and physiological stimula-
tion studies (see ref 40 for a review). By the 1930s, the
major neurological textbooks considered simple hallu-
cinations as localizing signs for lesions in the visuosen-
sory cortex, and complex hallucinations as localizing
signs for lesions in the visuopsychic cortex and its con-
nections to the temporal lobe.The idea fell out of favor
as it became clear that both simple and complex hallu-
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or outside the brain itself in the anterior visual path-
ways and eye.
40 Furthermore, it was unclear on what
grounds hallucinations traditionally considered simple
(eg, colored stars, leaping flames, or floating bubbles)
differed from hallucinations considered complex (eg,
faces or figures) as both experiences were fully formed
percepts.
40 Vestiges of the simple/complex dichotomy
survive to the modern era, complexity being a feature
of the redefined CBS and simple phenomena,variously
named photopsias or phosphenes,
41 studied as a sepa-
rate class of pathological visual perceptual experience
(see for example ref 42).
Heinrich Klüver and hallucinatory constants 
In studying the visual experiences associated with mesca-
line,Heinrich Klüver (1897-1979) identified three stereo-
typed phenomenological patterns which helped inform
clinical studies.
43The first related to geometrical patterns
(form-constants) which he divided into four classes:(i)
grating, lattice, checkerboard; (ii) cobweb; (iii) tunnel,
funnel;(iv) spiral.The second related to the perceptual
reduplication of objects (polyopia) and changes in per-
ceived size or shape,a syndrome he tentatively linked to
visual-vestibular interactions. The third related to
changes in the composition of objects with displacements
or rearrangements of object features.He argued that the
three symptom patterns were found in a range of clinical
disorders and reflected undefined neurobiological mech-
anisms.Although it never developed into a clinical clas-
sificatory scheme,the importance of the work is Klüver’s
Gestalt psychological perspective,viewing visual halluci-
nations as one of several variants of visual perceptual
experience,a position entirely consistent with emerging
neuroscientific evidence (see below).
Visual hallucinatory syndromes: present
Today’s clinical approach to visual hallucinations is very
much as it was in 1936,visual hallucinations being con-
ceived as a unitary pathological symptom distinct from
illusions.De Morsier’s convention of defining visual hal-
lucinatory syndromes by the neurological and psychiatric
context in which the hallucinations are found is still fol-
lowed for many conditions (eg,PD,DLB,or peduncular
lesions).However,with no consensus as to the cause of
CBS hallucinations,in the 1980s a novel approach was
formulated that looked back to the classical phenome-
nological tradition.
Phenomenological Charles Bonnet syndrome 
Until the 1980s, the CBS eponym and its surrounding
debate remained entirely within the French neurological
and psychiatric literature.However,in 1982,two groups
of British psychiatrists,by introducing the syndrome to a
wider international audience,initiated the modern era of
visual hallucinatory syndromes.
44,45 One group,Berrios and
Brook,presented a history of CBS in preparation for a
survey of visual perceptual problems in the elderly pub-
lished 2 years later.
46The other,Damas-Mora et al,wanted
to raise awareness of the syndrome to “obviate mistaken
psychiatric diagnosis.”Through translated extracts from
the classical French literature, Damas-Mora et al
abstracted core phenomenological features including hal-
lucination content (simple and complex forms), their
onset and temporal evolution,duration,relation to insight
and,echoing Leroy’s Lilliputian syndrome,their associa-
tion with a pleasant emotional tone. However, Damas-
Mora et al’s most important contribution was the implicit
recognition that there might be more than one type of
visual hallucination and that pure clinical forms might be
revealed by excluding certain disorders.For them,cogni-
tive impairment suggestive of dementia,secondary delu-
sions suggestive of psychosis and unpleasant distorted
experiences suggestive of delirium were inconsistent with
CBS hallucinations.This focus on phenomenology dis-
tanced CBS from the etiological debate, a move com-
pleted in 1989 by two American psychiatrists,Gold and
Rabins,
47 who argued that the syndrome should describe
a particular phenomenology until such time as the under-
lying pathophysiology became clear. Like the Capgras
syndrome related to brain lesions, schizophrenia, and
affective disorders,CBS could relate to a range of disor-
ders of the eye,brain,or metabolism.Refining Damas-
Mora et al’s core phenomenological features and exclu-
sions,Gold and Rabins presented a set of novel diagnostic
criteria focussing on complex hallucinations and remov-
ing the requirement of a pleasant emotional tone.They
also added that hallucinations in other modalities should
not be present,a feature that had been noted before (eg,
in the Lilliputian syndrome and the L’Hermitte and de
Ajuriaguerra 1936 case series),but had never been sug-
gested as a diagnostic criterion.It is the Gold and Rabins
CBS that is used in the current psychiatric literature.
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Gold and Rabins’ definition leaves clinicians with a
choice of three CBSs, illustrated in Figure 1. For de
Morsier (Figure 1a),CBS referred to a specific neurode-
generative condition and bore no relation to eye disease.
For de Ajuriaguerra (Figure 1b),CBS was the intersec-
tion of visual hallucinations and eye disease. For Gold
and Rabins (Figure 1c),CBS was a specific class of com-
plex visual hallucination divorced from clinical context.
Clinical research
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Figure 1. The three Charles Bonnet syndromes (CBS). Key figures in the history of each syndrome are shown, together with their definition and a rep-
resentation of the patients included. Blue rectangles = conditions associated with visual hallucinations; light green (simple) and dark green
(complex) rectangles = visual hallucinations, red dashed rectangle = eye disease. The subset of patients with CBS is shown in yellow, dark-
ened for those patients common to all three definitions. The size of each rectangle or its regions of intersection are not indicative of the num-
ber of patients involved. See text for further details. 
Portrait of de Morsier reproduced with permission of the Centre d'iconographie Genevoise, coll. BPU University of Geneva. Photo of de Ajuriaguerra reproduced
with permission of the University Hospital of Geneva. Photo of Peter Rabins reproduced with permission of Dr Rabins.
ABC
Visual hallucinations
in elderly with intact cognition
Visual hallucinations
in eye disease
                          Peter Rabins
Visual hallucinations which are:
A Formed
B Complex
C Persistent or repetitive
D Stereotyped
Insight is fully or partially retained
Absence of primary or secondary delusions
Absence of hallucinations in other modalities
Georges de Morsier
(1894-1982)
Julian de Ajuriaguerra
(1911-1993)More recent definitions are hybrids (eg,Menon et al use
1b and 1c in combination
48).Although some patients are
classified as CBS by all three schemes (the darkened
CBS subregion),the majority that meet diagnostic crite-
ria for one scheme will not do so for another.Thus stud-
ies using eye disease to define CBS (1b) may include
patients with auditory hallucinations and delusions that
would be excluded from de Morsier’s CBS (1a) or the
phenomenological CBS (1c).In contrast,studies using
phenomenological CBS (1c) may include patients with-
out eye disease,a logical impossibility in terms of CBS
(1b) which is defined by eye disease. Clearly, further
advance is hindered rather than helped by these concur-
rent traditions; but without an understanding of the
underlying cause of visual hallucinations it is unclear
which of the schemes to choose.All have clinical utility,
but none have resulted in an understanding of how to
investigate,treat,or manage visual hallucinations across
the range of clinical contexts.Indeed,one might argue
that patients with visual hallucinations today fare little
better than those of 70 years ago.
Current therapeutic options
No large-scale treatment studies of visual hallucinations
have yet been reported, evidence for the various drug
classes advocated being largely based on case report liter-
ature.The general consensus is that response to a given
medication class varies from patient to patient,an obser-
vation that may relate to the differing clinical contexts that
give rise to visual hallucinations.Table III outlines treat-
ment approaches that have been reported as successful in
some patients.In those with eye disease,reassurance may
be the only treatment required,with surgical ophthalmic
interventions improving hallucinations in some cases (see
ref 48 for review). In AD, the improvement of acuity
through provision of appropriate glasses may be enough
to reduce hallucinations.
49Antiepileptic medication can be
effective for hallucinations related to visual pathway
infarcts
50 or eye disease.
51 Both typical and atypical antipsy-
chotics have been tried in patients with eye disease with
varying success (see ref 48 for review). Cholinesterase
inhibitors may improve hallucinations, particularly in
patients with cognitive impairment.
52 Serotonin (5-HT)3
antagonists have been effective in treating visual halluci-
nations in both PD
53 and eye disease,
54 although cisapride
has been withdrawn in many countries.Acetazolamide
increases cerebral blood flow,has antiepileptic properties,
reduces intraocular pressure,and improves visual halluci-
nations in the context of migraine aura status.
55 Finally,de
Ajuriaguerra reported that visual hallucinations in a sub-
set of patients with dementia responded to the arousing
effects of methylphenidate hydrochloride (Ritalin).
27
Neurophenomenological syndromes: 
the future
Our current approach to visual hallucinatory syndromes
remains heavily influenced by the 1936 formulation of
visual hallucinations as a unitary pathological symptom,
distinct from illusions,with content of little significance.
However, recent advances in perceptual neuroscience
question these core assumptions.Imaging studies of the
visual system have identified activations in occipital,tem-
poral,limbic,and parietal cortices,each with a relative
specialization for a range of visual attributes (see ref 14
for review of areas relevant to visual hallucinations).The
conscious experience of seeing a visual attribute present
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Table III. Treatment approaches. 5-HT, serotonin; CNS, central nervous system
Reassurance Mainstay of treatment for patients with self-limiting visual hallucinations related to eye disease.
Ophthalmic intervention Hallucinations may resolve after treatment of ophthalmic condition eg, cataract extraction or correction of 
refractive error.
Antiepileptics Carbamazepine, sodium valproate, phenytoin, and gabapentin may be helpful in visual hallucinations 
related to visual pathway infarcts or eye disease.
Antipsychotic  A range of typical and atypical neuroleptics have been used to treat visual hallucinations associated with eye
disease, with mixed success.
Cholinesterase inhibitors Donepezil may improve visual hallucinations, particularly in patients with cognitive impairment.
5-HT Cisapride and Ondansetron have been used to treat visual hallucinations in both Parkinson’s disease and 
eye disease.
Cerebral blood flow Acetazolamide has been used to treat the visual hallucinations of migraine aura status.
CNS stimulants Methylphenidate hydrochloride (Ritalin) reduces visual hallucinations in patients with dementia.in the world around us (referred to here as a veridical
percept) is linked to activity within such specialized
visual areas—activity within an area greater when its spe-
cialized attribute is perceived compared with when it is
not.
56-58 For example, the veridical percept of a moving
stimulus is associated with a larger response in motion
specialized cortex than is evoked by the same stimulus
when it is not perceived.
56 Whether this increment in
response marks activity that is,in itself,sufficient for the
conscious experience of motion is disputed (see ref 59 for
overview of the debate).Visual hallucinations (referring
here to externalized percepts of visual attributes that are
not present in the world around us),are associated with
spontaneous activations of the same specialized visual
areas,the content of a hallucination being defined by the
location of the spontaneous activity.
60Thus,the halluci-
nation of an object is associated with spontaneous activ-
ity in object-specialized cortex,the hallucination of a face
with spontaneous activity in face-specialized cortex,and
so forth.Activity is found in specialized visual areas both
when insight is present (pseudohallucinations in one
sense of the term) and when it is not.
61The visual illusion
disorders encountered clinically (eg, metamorphopsia
and palinopsia—see ref 62 for a review) have not been
studied extensively with neuroimaging; however, it is
likely that these experiences also relate to activity within
specialized visual cortex,as nonclinical visual illusions
(eg,Kanizsa figures) activate the same areas.
63,64A recent
case study of facial metamorphopsia is consistent with
this view.
65Afterimages,
66 synesthetic experiences,
67 and
rapid eye movement (REM) sleep,
68 are all associated
with activity increases in specialized visual areas.In con-
trast,visual imagery (visual perceptual experiences in the
“mind’s eye”) seems to have a different neurobiological
substrate (see,for example,ref 69 in relation to color).
Although specialized visual areas may be involved in
imagery, the predominant activations are found in the
frontal and parietal lobes,
70 with feedback from these
regions to the visual cortex.
71
Figure 2 displays visual perceptual experiences on three
phenomenological axes,one related to their perceptual
locus (external or in the mind’s eye), a second to the
sense of agency or volitional control the subject has over
them,and a third to their vividness.Veridical percepts,
visual hallucinations (with and without insight), visual
illusions,and visual afterimages are all located externally,
and are devoid of a sense of agency but vary in terms of
their vividness. For example, visual hallucinations of
colour are often described as hyperintense (hyperchro-
matopsia
62),while afterimages are typically vague.In con-
trast, visual imagery appears in the mind’s eye and is
entirely under volitional control.Other visual perceptual
phenomena have mixed properties.Eidetic imagery and
lucid dreams are external and vivid but under volitional
control,pseudohallucinations (in the sense of experiences
occurring in the mind’s eye) lack a sense of agency,as do
post-traumatic stress disorder (PTSD) flashback phe-
nomena. Synesthetes also lack a sense of agency over
their synesthetic experiences,but fall into two groups,one
experiencing the phenomena externally (projectors),the
other in the mind’s eye (associators).
72Although imaging
evidence is lacking for many of these visual perceptual
phenomena, a clear and striking pattern emerges for
those that have been studied,the combined phenome-
nological and neurobiological approaches resulting in
what I have termed a neurophenomenological classifica-
tion.
14 From a neurobiological perspective,the phenom-
enal space is divided into two broad regions (left and
right of the dotted vertical plane in Figure 2).The pre-
dominant brain activation associated with experiences to
the left of the figure (perceived externally) lies within
specialized visual areas. In contrast, the predominant
brain activation associated with experiences to the right
of the figure (in the mind’s eye) lies within frontal and
parietal regions.Thus,a veridical percept of motion,
56 an
illusion of motion,
63 and an afterimage of motion
66 are all
linked to activity within motion-specialized cortex. In
contrast, imagery of motion involves predominantly
frontal activations.
73 Synesthetic visual experience has
also been linked to activity within specialized visual cor-
tex,
67 although it is not clear whether this is the case for
both projectors and associators.
Emerging visual perceptual syndromes 
The various visual phenomena illustrated in Figure 2 are
classified within our current psychiatric and philosophi-
cal taxonomies as distinct entities,differences between
them based on their relation to external objects and to
insight,with little attention paid to their content.Thus,
a face hallucination is considered a distinct class of expe-
rience from a face illusion in a cloud formation,but not
from the hallucination of a landscape.Yet,viewed from
a neurophenomenological perspective,the same percep-
tual experiences are classified in an entirely different way.
Here,the face illusion and hallucination are considered
Clinical research
182to be closely related, both involving the same cortical
area, but are distinct from the landscape hallucination
which involves a different area.In the neurophenome-
nological classification,the content of perceptual experi-
ence becomes of central importance while traditional dis-
tinctions between illusions and hallucinations are
de-emphasized.This is not to say that veridical percepts,
illusions,and hallucinations of a given visual attribute are
identical in terms of the underlying neural circuitry
within a specialized area.However,it is clear is that these
traditionally distinct experiences are more closely related
than previously suspected.
The neurophenomenological perspective undermines key
shifts in emphasis in the approach to visual hallucinations
and their syndromes instituted in 1936.In neurobiological
terms,visual hallucinations are not unitary phenomena,
different contents pointing to different cortical loci,and
are not distinct from illusions.Neurophenomenological
building blocks construct syndromes that have been
obscured in our traditional classificatory systems that are
perhaps now more appropriately termed visual perceptual
syndromes than visual hallucinatory syndromes.Figure 3
shows a range of visual perceptual symptoms cross-tabu-
lated with their associated conditions and color-coded to
reflect the relative frequency of each symptom within
those patients that have visual perceptual pathology.Three
syndromes emerge that appear to be distinct both in their
pattern of content and the fact that they remain largely
independent—patients with one syndrome rarely devel-
oping the same mixture of visual symptoms as found in
another. One syndrome (prototypical disorder macular
disease–see ref 74) consists of a range of simple phenom-
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Figure 2. The neurophenomenological classification of visual perceptual experience. A three-dimensional space is represented with axes: (i) percep-
tual locus – external or in the mind’s eye; (ii) sense of agency or volitional control; (iii) vividness (also coded by color saturation). Each class of
visual perceptual experience is represented by a sphere. The dotted vertical plane divides those experiences related predominantly to activity
in specialized visual cortex (left of figure) from those experiences related predominantly to activity in a network of parietal and frontal areas
(right of figure). See text for further details.ena including tessellopsia (brickwork and lattice patterns)
62
and multiple dots (visual snow).Although the simplest of
these phenomena may have their origins in aberrant reti-
nal firing (eg,flashes or sparks),they can also be elicited
by direct stimulation of the visual pathways and cortex
41
and, given this ambiguity, it seems reasonable to keep
them within the classificatory scheme at present.The sim-
ple phenomena as a whole are associated to varying
degree with more complex symptoms forming subsyn-
dromes.
74 One subsyndrome consists of visual persevera-
tion (an object or object feature remaining fixed in retinal
co-ordinates as the eye moves), delayed palinopsia (an
object or object feature returning to the field of view after
a delay) and the appearance of hallucinations in the
peripheral visual field.Another subsyndrome consists of
faces,typically grotesque with prominent features and a
cartoon or sketch-like quality.The third subsyndrome is
reminiscent of Leroy’s Lilliputian hallucinations.Each of
these subsyndromes seems to relate to pathological activ-
ity in a different cortical locus,the first to the parietal lobe,
the second to the superior temporal sulcus,and the third
to the anterior ventral temporal lobe.
74When other causes
of visual hallucinations have been excluded,these symp-
toms occur without hallucinations in other modalities and
without delusions.This syndrome is the Gold and Rabins
CBS,broadened to include simple hallucinations and illu-
sions (caricatured in Figure 4 CBS) and is found in both
eye disease
75 and pathology of the visual pathways.
50,76-78 In
1973, the American neurophthalmologist David Cogan
hypothesized that such phenomena result from the release
of visual cortical activity following the loss of visual
inputs.
79Although today release is perhaps better termed
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Figure 3. Visual perceptual syndromes. A range of clinical conditions (columns) are cross-tabulated with visual symptoms (rows). Of patients with visual
perceptual pathology in a given condition, the percentage reporting each symptom category is coded red (>20%), pink (10% to 20%) or
white (not reported or <10%) See text for source references. Multimodal refers to visual hallucinations occurring in combination with those
in another sensory modality, either simultaneously or on separate occasions. No systematic phenomenological surveys of visual perceptual
phenomenology have been performed for peduncular lesions, migraine aura, persistent positive visual phenomena (PPVP) in migraine, 5-HT2
antagonism, vestibular disorders or MDMA use, the percentage coding in these disorders is therefore estimated from case reports. The green,
red, and purple rectangles demarcate three syndromic patterns. See text for further details. PD, Parkinson's disease; AD, Alzheimer's disease;
DLB, dementia with Lewy bodies; LSD; lysergic acid diethylamine; 5-HT, serotonin, MDMA, 3,4-methylenedioxymethamphetamine.deafferentation (see ref 80 for updated neurophysiology),
there is much indirect evidence to support the view (eg,an
increase in the risk of CBS with greater visual loss
81-83).
However, Terson’s 1920s critique of the ocular theory
remains as relevant today as it was when first mooted.
Deafferentation alone fails to account for why only a small
proportion of ophthalmic patients experience visual hal-
lucinations.
The second syndrome (prototypical disorder PD—see
refs 39,84,85) differs from the first in the conspicuous
absence of simple hallucinations.Patients experience illu-
sions and fully formed hallucinations,typically of mun-
dane figures or animals (caricatured in Figure 4 Ach).
The visual symptoms are often associated with extra-
campine and multimodality hallucinations and delusional
elaboration.AD,
86,87 DLB,
88 and peduncular lesions
89 are
associated with a similar syndrome which seems to relate
to ascending brainstem neurotransmitter dysfunction,
particularly in the cholinergic system
14 (see ref 90 for
review of cholinergic hypothesis).The third syndrome
(prototypical disorder LSD flashback
91—now hallucino-
gen persisting perception disorder [HPPD]
92) consists of
tessellopsia,visual snow,palinopsia,polyopia (multiple
copies of an object) and metamorphopsia (caricatured in
Figure 4, 5-HT). Patients rarely experience complex
visual hallucinations,delusions,or hallucinations in other
modalities.The same spectrum of disorders is described
in the classical peripheral and central vestibular lesion lit-
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Figure 4. Caricatures of the deafferentation (CBS), cholinergic (Ach) and serotonergic (5-HT) visual perceptual syndromes. The deafferentation syndrome
has three subsyndromic forms shown as light green regions. top = parietal; middle = superior temporal; bottom = ventral temporal)erature,
93 migraine aura,and migraine aura status (per-
sistent positive visual phenomena),
94,95 MDMA,
96 and 5-
HT2 antagonism.
97Although the underlying mechanism
of this syndrome is unclear, many of the conditions in
which it occurs are linked to the serotonergic system.
Figure 5 outlines a treatment algorithm for the three
visual perceptual syndromes.For each,it is important to:
i) review medication to minimize anticholinergic load;ii)
consider whether the syndrome may have been precipi-
tated by concurrent infection (often a urinary tract infec-
tion in the elderly);and iii) if necessary,optimize vision.
The question of whether to investigate depends largely
on the match between the syndrome and clinical context.
Hallucinations of a familiar dog in a patient with
Parkinson’s disease would not warrant further investiga-
tion,but hallucinations of grid patterns confined to one
hemifield might prompt neuroimaging of the visual path-
ways and cortex.Similarly,prolonged hallucinations of
whispering figures in a patient with macular disease
might prompt a psychiatric review,whereas a brief hal-
lucination of an Edwardian tea party would not. CBS
may be treated with the reassurance of a likely resolution
with time,although patients may be warned that symp-
toms can re-occur following further visual deterioration.
For anticholinergic syndrome phenomena that are not
distressing,restricted to the visual modality,and not asso-
ciated with persistent secondary delusions,patients may
be managed with reassurance,although the experiences
are likely to persist and progress.For CBS phenomena
that persist and are distressing or Ach syndrome phe-
nomena that are distressing,multimodal,or have persis-
tent delusions,medication can be considered,the class is
chosen depending on clinical context. Cholinesterase
inhibitors would be a logical first choice for patients with
cognitive impairment, while antipsychotics may be
appropriate for those with pronounced delusions.
Management of the 5-HT syndrome is unclear;however,
acetazolamide or benzodiazepines may have a role in the
specific contexts of migraine aura status
55 and HPPD.
91
Conclusions
The legacy of past visual hallucinatory syndromes has
been confusion and obfuscation,questioning the wisdom
of another classificatory scheme.Why add further com-
plication to an already complex field? The answer lies in
the possibility that the neurophenomenological
approach,and syndromes derived from it,reveal features
hidden in our traditional taxonomies by bringing us
closer to the underlying pathophysiology.The emerging
neurobiological insights may ultimately fulfil the early
20th-century aspiration that specific hallucination phe-
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Figure 5. Treatment algorithm for the three visual perceptual syndromes. CBS, Charles Bonnet syndrome; Ach, anticholinergic; 5-HT, serotonin
• Review anticholinergic load 
• Exclude concurrent infection / delirium
• Optimise vision  
• Reassurance
• Patient support groups
• Ophthalmological intervention 
Not distressing, visual modality only, 
no secondary delusions
• Reassurance
Unclear 
? Acetazolamide
? Benzodiazepine 
CBS Ach syndrome
• Cholinesterase inhibitor
• Antiepileptic
• Atypical antipsychotic
5-HT syndrome 
Further investigations if mismatch 
between hallucinations and 
clinical context 
Distressing, multimodality, 
secondary delusions Persistent, 
distressing nomenology points to a specific etiology.The evidence
presented above tentatively links each syndrome to dys-
function within afferent, cholinergic, or serotonergic
visual circuitry;however,this will be an oversimplifica-
tion. Furthermore, even if correct, visual perceptual
pathology related to pure deafferentation,pure cholin-
ergic,or pure serotonergic dysfunction is likely to be the
exception rather than the rule in routine clinical practice.
Yet despite this undoubted weakness,the identification
of distinctive patterns of visual perceptual pathology may
prove to be the key to understanding the investigation
and treatment of the experiences.How the relative con-
tributions of the differing mechanisms can be assessed
are questions for the future.For now we must be content
with the possibility that insights from perceptual neuro-
science will take us past the 70 years of controversy and
revitalise visual hallucinatory syndromes for future gen-
erations of clinicians. ❏
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Síndromes alucinatorios visuales: 
pasado, presente y futuro
En 1936, dos revisiones clínicas (una de De Morsier
y la otra de L’Hermitte y Ajuriaguerra) formularon
una aproximación a las alucinaciones visuales que
se mantiene hasta el día de hoy. Alejándose de las
tradiciones previas, este artículo aboga porque las
alucinaciones visuales sean dignas de estudio por
derecho propio, sin hacer énfasis en el significado
clínico de sus contenidos visuales y tomando dis-
tancia de las ilusiones visuales. De Morsier describió
un conjunto de síndromes alucinatorios visuales
basados en un contexto neurológico y psiquiátrico
más extenso, muchos de los cuales son hasta hoy
día relevantes; sin embargo, uno de ellos –el
Síndrome de Charles Bonnet- ha motivado 70 años
de controversia acerca del rol del ojo. En este artí-
culo se revisa la historia del conflicto entre los sín-
dromes alucinatorios visuales y el ojo, junto con los
avances en las neurociencias de la percepción que
cuestionan las principales hipótesis de la aproxima-
ción actual. Desde una perspectiva neurobiológica
surgen tres síndromes que se relacionan con dis-
funciones específicas de los circuitos visuales afe-
rentes, colinérgicos y serotoninérgicos, y prometen
futuros avances terapéuticos.
Syndromes hallucinatoires visuels : 
passé, présent et futur
Deux études cliniques, décrites en 1936 par de
Morsier et de L’Hermitte et Ajuriaguerra, ont pré-
senté une approche des hallucinations visuelles qui
perdure aujourd’hui. Rompant avec les traditions
antérieures, ils défendent dans leurs articles les hal-
lucinations visuelles comme dignes de sujet
d’études, minimisant la signification clinique de leur
contenu visuel et les différenciant des illusions
visuelles. De Morsier a décrit un ensemble de syn-
dromes hallucinatoires visuels rentrant dans un large
cadre neurologique et psychiatrique dont la plupart
demeurent pertinents actuellement ; l’un d’entre
eux, le syndrome de Charles Bonnet, a fait néan-
moins l’objet de controverses durant 70 ans au sujet
du rôle de l’œil. L’anamnèse des syndromes hallu-
cinatoires visuels et la discussion sur l’œil sont ici
analysées à la lumière des avancées des neuros-
ciences de la perception qui remettent en question
les hypothèses centrales de notre approche actuelle.
D’un point de vue neurobiologique, trois syndromes
se distinguent en se rattachant à un dysfonctionne-
ment spécifique des circuits visuels sérotoniner-
giques, cholinergiques et afférents ; ils sont pro-
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